Neutral
Solventum Corporation (NYSE: SOLV) has settled a class-action lawsuit regarding its by-laws, agreeing to pay $120,000 in attorney fees without admitti...
Neutral
Solventum Corporation (SOLV) experienced a decline due to concerns over AI disruption impacting its Health Information Systems (HCIT) unit, which cons...
Neutral
Trian Fund Management, a major shareholder in 3M spinoff Solventum, is escalating an activist campaign to improve the company's performance, criticizi...
Bullish
Wedbush has initiated coverage on Solventum (NYSE:SOLV) with an Outperform rating and a $94.00 price target, identifying it as a compelling special si...